UTI

UTI (Universal Technical Institute, Inc.) Analyst Note

Date: 2026-06-20 Event Date: 2026-06-20

1. Structural Readiness

• Conservative Entry: $37.40
• Current Price: $40.35
• Extension: +7.9% above conservative entry.
• Breakout Level: $37.40 (Conservative Entry).
• Volatility Context:
• ATR at Breakout: 4.3% (High structural quality).
• Current ATR: 6.0% (Very High).

2. Thesis Layer

• Thesis Classification: TACTICAL / Setup-Led.
• Macro Thesis Status: None.
• Analysis: As of 2026-06-20, there is no named secular macro thesis attached to this specific trade setup. The conviction for this position is derived entirely from the structural quality of the "Coil" formation (confirmed breakout with high structural ATR) and the fundamental execution of the business plan as reported by management. The trade is not driven by a specific macro narrative (e.g., "AI boom" or "Energy transition") but by the alignment of a high-quality technical setup with a company executing a clear growth roadmap.

3. Business Fundamentals

• Core Business: UTI operates as a leading workforce solutions provider, delivering technical training in transportation, skilled trades, and allied health.
• UTI Division: Operates 16 campuses in nine states (as of March 31, 2026), offering degree and non-degree programs in automotive, diesel, collision, and energy sectors.
• Concorde Division: Operates 18 campuses in eight states and online, offering programs in allied health, dental, nursing, and patient care.
• Revenue Model: Primary revenue is derived from tuition and fees. A substantial portion of student funding relies on federal financial aid (Title IV) and veterans' benefits.
• Growth Execution (Management Expectations):
• Revenue Guidance: Management expects consolidated revenue for fiscal 2026 to range between $905 million and $915 million, representing approximately 9% year-over-year growth at the midpoint.
• Long-Term Targets: Management targets revenue exceeding $1.2 billion by fiscal 2029, with a 10% CAGR throughout that period. Adjusted EBITDA is projected to approach $220 million by fiscal 2029.
• Campus Expansion:
• San Antonio: Opened March 2026; early starts exceeded plans by nearly 60%. Projected mature run rate is ~800 students.
• Atlanta: First comprehensive UTI campus in the state, expected to serve over 1,500 students at scale.
• New Leases: As of May 2026, leases were signed for Salt Lake City (UTI), Atlanta (Concorde), Houston (Concorde), and Glendale (Concorde). These are expected to open in fiscal 2027 pending regulatory approval.
• Program Pipeline: Management expects to launch a minimum of six new programs annually at existing campuses and open at least two new campuses each year between fiscal 2026 and 2029.
• Market Demand: Management cites U.S. DOL BLS data estimating 111,100 annual job openings for automotive/diesel/collision technicians and 1,286,700 for healthcare support occupations through 2034.
• Financial Health:
• EBITDA: Baseline adjusted EBITDA anticipated to exceed $150 million for fiscal 2026.
• Liquidity: In April 2026, the company used cash on hand to repay $65.0 million on its Credit Facility, increasing availability to $105.4 million.
• Regulatory: A $19.6 million letter of credit was issued in July 2025 to lift core growth restrictions on Concorde and UTI campuses following the acquisition.

4. Archetype and Conviction

• Archetype: Quality Compounder.
• Rationale: The company fits the "Quality Compounder" archetype due to its consistent execution of a multi-year growth plan, strong demand fundamentals in the trades/healthcare sectors, and disciplined capital allocation (debt repayment, strategic campus openings). The business model demonstrates durability with double-digit growth in student starts (14% YoY in the most recent quarter) across both divisions.
• Conviction Stack:
• Thesis Strength: Moderate (Tactical setup, no external macro tailwind).
• Evidence Quality: High. Multiple primary sources (earnings transcripts, SEC filings) confirm revenue guidance, campus ramp-up success, and regulatory clearance.
• Structural Quality: High. The setup features a "High" ATR at breakout (4.3%), indicating strong momentum at the inflection point.
• Rerating Potential: Moderate to High. The market is pricing in the successful ramp-up of new campuses (San Antonio, Atlanta) and the expansion into new geographies (Salt Lake City, Houston, Glendale).
• Volatility Note: The current ATR of 6.0% ("Very High") suggests the stock is experiencing elevated volatility post-breakout. While this increases the risk of short-term drawdowns, it is consistent with the "Quality Compounder" archetype during periods of aggressive expansion and earnings realization.

5. Invalidations, Strengtheners, and Gaps

• Invalidation Triggers:
• Fundamental: A significant miss on the fiscal 2026 revenue guidance ($905M–$915M) or a failure of new campuses (e.g., San Antonio or Atlanta) to meet enrollment targets (e.g., <60% of plan) would undermine the "Quality Compounder" thesis.
• Regulatory: Loss of Title IV eligibility or failure to lift growth restrictions on Concorde campuses would be a critical failure.
• Strengtheners:
• Operational: Confirmation that the Salt Lake City, Houston, and Glendale campuses open on schedule in fiscal 2027.
• Financial: Earnings reports showing adjusted EBITDA exceeding the $150 million baseline or student starts continuing to grow >14% YoY.
• Strategic: Successful ramp-up of the Porsche training centers (1,000+ graduates) leading to expanded partnerships.
• Evidence Gaps:
• Margin Detail: While EBITDA is guided, specific gross margin expansion drivers for the new campuses are not detailed in the provided evidence.
• Debt Maturity: The specific maturity schedule of the remaining debt post-$65M repayment is not explicitly detailed in the provided snippets, though liquidity is improved.
• Enrollment Mix: The specific breakdown of federal aid vs. private payment mix for the new campuses is not provided.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: high Key evidence: Confirmed breakout above $37.40 with price holding at $40.35; Management guidance for 9% revenue growth in FY2026 and $1.2B revenue by FY2029; Successful ramp-up of San Antonio campus exceeding plans by 60%. Key risks: Elevated current ATR (6.0%) indicating high volatility; Regulatory delays on new campus openings in fiscal 2027; Potential reduction in federal financial aid eligibility. Sizing hint: Standard position sizing for a confirmed coil; reduce size slightly if intraday volatility exceeds 6% ATR. Expected path: Management executes on campus openings in fiscal 2027, driving revenue toward the $905M-$915M FY2026 range and validating the 10% CAGR path to 2029. Expected horizon: 12 to 18 months for the full thesis to play out as new campuses reach scale.